Showing 6911-6920 of 20410 results for "".
The Meeting of Hair Care and Skin Care
https://reachmd.com/programs/practical-dermatology/tbd/39736/Iris Rubin, MD, FAAD, discusses integrative approaches at the intersection of hair care and skin care. This video was recorded at the Science of Skin Summit in Austin, TX.What’s New in Rosacea Treatments?
https://reachmd.com/conferences/science-of-skin-summit-2025/tbd/39737/James Q. Del Rosso, DO, FAOCD, reviews the latest therapeutic innovations and evidence in rosacea management. This video was recorded at the Science of Skin Summit in Austin, TX.Examining Care Collaborations for Patients with SMA
https://reachmd.com/programs/neurofrontiers/examining-care-collaborations-for-patients-with-sma/36618/Collaborative care plays an important role in treating patients is spinal muscular dystrophy (SMA). To learn more about this, Dr. Andrew N. Wilner is joined by Drs. Vanessa Battista and Nassim Rad to share their insights on team structures and collaborative care for SMA.Keys to Slowing Disease Progression in SMA
https://reachmd.com/programs/neurofrontiers/keys-to-slowing-disease-progression-in-sma/36616/Spinal muscular atrophy (SMA) is a rapidly progressive disease, but current treatment options might help us slow its progression. Dr. Charles Turck explores these treatment options with Dr. John Brandsema from the Perelman School of Medicine at the University of Pennsylvania.Helping Kids Thrive: Addressing Eczema Early with Systemic Therapies
https://reachmd.com/programs/dermconsult/helping-kids-thrive-addressing-eczema-early-with-systemic-therapies/35498/From chronic sleep disruption to lasting developmental and psychological impacts, untreated eczema carries profound risks for children. But timely intervention with systemic options may help children regain sleep, joy, and daily function, especially when topical therapies fall short. Learn more withJournal Club: Dupilumab and Atopic March
https://reachmd.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-dupilumab-and-atopic-march/32405/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Editorial Board member Peter Lio, MD, discuss recent research indicating a reduced risk of atopic march in pediatric atopic dermatitis patients on dupilumab.Lin TL, Fan YH, Fan KS, Juan CK, Chen YJ, Wu CY. ReducedSeborrheic Dermatitis Approaches and Stopping Biologic Treatment for Atopic Dermatitis
https://reachmd.com/conferences/scale-2025/seborrheic-dermatitis-approaches-and-stopping-biologic-treatment-for-atopic-dermatitis/35896/Naiem T. Issa, MD, PhD, talks at Music City SCALE 2025 about how to approach seborrheic dermatitis, as well as what happens to atopic dermatitis patients after ending biologic treatments.Fractional Lasers for NMSC and More
https://reachmd.com/conferences/scale-2025/fractional-lasers-for-nmsc-and-more/35876/Joel L. Cohen, MD, FAAD, and Matthew M. Avram, MD, talk about research involving fractional lasers, including as part of combination treatments for nonmelanoma skin cancer, at Music City SCALE 2025.Procedural Management for HS
https://reachmd.com/programs/practical-dermatology/procedural-management-for-hs/35891/Vivian Shi, MD, talks about procedural management for hidradenitis suppurativa and how to incorporate those procedures with medical management of the condition at Music City SCALE 2025.Pediatric Responses to SARS-CoV-2: What We’ve Learned So Far
https://reachmd.com/programs/clinicians-roundtable/pediatric-responses-to-sars-cov-2-what-weve-learned-so-far/35464/Since the start of the COVID-19 pandemic, our understanding of how children respond to the virus has grown significantly. Join Dr. Diego Hijano as he breaks down these advancements, including how pediatric immune responses and conditions like multisystemic inflammatory syndrome can inform the way we